1.20 -0.18 (-13.24%)
ARIA
Stock Details
Last Trade:1.20 Change:-0.18 (-13.24%) Prev Close:1.38 Open: 1.36 Days Range:1.18 – 1.40 52 Week Range: 1.15 - 4.87 Volume:280385 P/E: N/AEPS:-1.02
View AllRecent Alerts 11/21/08
Recent Alert on 11/06/08 at 8:34am
Ariad Pharmaceuticals (ARIA) Misses Q3 View; Guides
Ariad Pharmaceuticals (ARIA) Misses Q3 View; Guides
Ariad Pharmaceuticals (Nasdaq: ARIA) reports Q3 loss of $0.29, cents better than the analyst estimate of ($0.30). Revenue for the quarter was $1.54 million, versus the consensus of $2.39 million. Ariad Pharmaceuticals sees FY08 loss $73M-$75M,... Read More
Recent Alert on 10/24/08 at 7:38am
ARIAD Pharmaceuticals (ARIA) Presents Data on Its Kinase Inhibitor Which Demonstrated Mechanism-Based Activity in Solid Tumors
ARIAD Pharmaceuticals (ARIA) Presents Data on Its Kinase Inhibitor Which Demonstrated Mechanism-Based Activity in Solid Tumors
Recent Alert on 10/21/08 at 10:51am
Susquehanna Initiates Coverage on Ariad Pharmaceuticals (ARIA) with a Positive
Susquehanna Initiates Coverage on Ariad Pharmaceuticals (ARIA) with a Positive
Recent Alert on 09/22/08 at 8:03am
ARIAD Pharmaceuticals (ARIA) Announces Disappointing Ruling Regarding NF-(kappa)B Patent Lawsuit with Amgen (AMGN)
ARIAD Pharmaceuticals (ARIA) Announces Disappointing Ruling Regarding NF-(kappa)B Patent Lawsuit with Amgen (AMGN)
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 05/16/08 at 5:56am
Oncology Conference Countdown: What Will Pharma and Biotech Companies Report?
Oncology Conference Countdown: What Will Pharma and Biotech Companies Report?